Biorhythms. (biotechnology stocks) From: The Economist (US) | Date: July 3, 1993 | COPYRIGHT 1993 Economist Newspaper Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

A British biotechnology firm got the London Stock Exchange to waive its rule to not list companies before they establish a three-year record of profits. Biotech companies are attracting investors because drug companies have not been performing well.

A YEAR ago British Bio-technology, a biotech drugs firm, persuaded the London Stock Exchange to waive its usual rule that a firm must have a three-year profit record before it can be listed. The firm successfully raised Pounds 30m ($53m), valuing it at Pounds 152m. The share price has held steady since then. This looks odd. For on June 29th ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

	50% of country's biotech firms based in Karnataka. ; ...50 percent or 131 of the 265 domestic biotech firms, were in Karnataka. Of these, 127 are...be evenly spread -- 18 percent are agri-biotech firms, while 17 percent were biotech firms. Supply companies (those who supply raw...
	Financial support for biotech firms.(LETTERS) ; ...nature of business risk facing small biotech firms, it is natural that groups of investors...case for restoring federal grants to biotech firms in his Wednesday Op-Ed column, which...allow the free market to decide which biotech firms and which new drugs to back. The fact...
	NORFOLK LURING BIOTECH FIRMS.(BUSINESS) ; ...building space to partner with area biotech firms on several projects. On hand to discuss...opportunities and some tips for nurturing biotech firms will be Dr. Alpha Diallo with Norfolk...Norfolk is interested in attracting biotech firms, despite their notorious risk, because...
	Biotech Firms Get to Polish Their Pitch at Colorado Forum. ; ...Beauprez Mar. 1--Colorado's cutting-edge biotech firms want the ear of investors, but explaining...is tough. The founders of 10 young biotech firms got the chance to practice Thursday...In the past four months, two local biotech firms, Pharmion Corp. and Myogen Inc., snagged...
	Cuts in federal grants to small biotech firms to be restored.(HEALTH CARE)(Brief Article) ; Cuts in federal grants to small biotech firms will be restored. But it may take months, forcing researchers...are disqualified from SBIR funding. It affects most small biotech firms. Capitol Hill is coming to the rescue with new legislation...
	Congress will prod SBA to let more small biotech firms get grants.(SMALL BUSINESS) ; Congress will prod SBA to let more small biotech firms get grants under the Small Business Innovation Research program...under the program, but the biotechnology industry says small biotech firms are now unable to obtain needed federal funds.
	Biotech firms urged to adapt ; ...biotech companies in Scotland. Many of Britain's decade-old biotech firms have suffered from a relative lack of success and the industry...no consolation for being fourth or fifth best in a field. Biotech firms must seek to play leading roles on a global basis or put...
	All gone but the money When product fails, some biotech firms faced with deciding what to do with leftover cash ; ...existing drugs to fund new ones, most biotech firms lack any financial backup. So small biotech firms are almost always under an investor...their Internet portfolios, some young biotech firms with promising drug candidates can...
	Biotech Firms Take On 1940 Investment Law, Seek Exemption from SEC's Purview. ; ...are the same. An increasing number of biotech firms said they're afraid of running afoul...the SEC to provide an exemption for biotech firms and others engaged in long-term research...Ferris Glovsky and Popeo who advises biotech firms on financing strategies, This has always...
	Big is beautiful: Large biotech firms are in fashion. Small ones are more unpopular than ever.(Brief Article) ; ...few ideas on the boil. Yet most small biotech firms have little more to offer. According...almost half of the country's 327 public biotech firms have less than two years-worth of cash...plays that role. One way for small biotech firms to raise their profile is through merging...

For more facts and information, see all results